Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva

Stopped early · Phase 2

Conditions studied: Cervical Cancer Stage IV, Vulvar Cancer, Stage IV

In brief

Current therapies for Stage IV Cancer of the Cervix and/or Vulva provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of Stage IV Cancer of the Cervix and/or Vulva. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on patients with Stage IV Cancer of the Cervix and/or Vulva.

Key facts

Study ID

NCT00003525

Run by

Burzynski Research Institute

People needed

8

Starts

1996-06-03

Expected to finish

1998-01-22

Last updated by the study team

2017-09-29

Who can join

Age: 18 and older, up to 99. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Burzynski Clinic — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.